A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
DualityBio Inc.
Esperas Pharma Inc.
Mundipharma Research Limited
Pfizer
Nektar Therapeutics
Kiadis Pharma
NKGen Biotech, Inc.
Southwest Hospital, China
Rexahn Pharmaceuticals, Inc.
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center